BNTC 8-K 2026-09-30

Benitec Biopharma Inc. (BNTC) 8-K dated 2026-09-30 — accession 0001193125-26-409052. This URL is the filing, not the BNTC hub.

Benitec Biopharma Inc. (BNTC) is a biotechnology company listed on NASDAQ.

Benitec Biopharma Inc. filed a 8-K on 2026-09-30. Accession 0001193125-26-409052.

Cached items: 4.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported BNTC revenue for 2024-06-30 was $0. Net income was -$21.8M. Revenue was down 100.0% from 2023-06-30 to 2024-06-30. BNTC currently screens at market cap $388.7M.

Not investment advice. The BNTC SEC hub lists recent forms. The stock page is the research view.